Findings

What do systematic reviews say?

1 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%

Levamisole vs cyclophosphamide

Relapse · SSNS in children

Levamisole showed no clear difference in relapse: at 6 to 9 months after therapy compared with cyclophosphamide (low certainty).

3 findings from 1 review

Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
RR 1.17 [0.76, 1.81]
2 studies · 97 participants
Low
Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
RR 0.89 [0.68, 1.16]
1 study · 40 participants
Low
Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
RR 0.89 [0.73, 1.1]
1 study · 40 participants
Low